Peroxisome Proliferator-Activated Receptors and the Cardiovascular System

Vitamins and Hormones

Volumn 66, Issue , 2003, Pages 157-188

  Chen, Yuqing E ^a   Fu, Mingui ^a   Zhang, Jifeng ^a   Zhu, Xiaojun ^a   Lin, Yiming ^a   Akinbami, Mukaila A ^a   Song, Qing ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL; ANTIBODY SPECIFICITY; ARTERIOSCLEROSIS; BLOOD VESSEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; GENETICS; HUMAN; HYPERTENSION; PHYSIOLOGY; REVIEW;

ANIMALS; ARTERIOSCLEROSIS; BLOOD VESSELS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGY; CARDIOVASCULAR SYSTEM; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION; ORGAN SPECIFICITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS; VARIATION (GENETICS);

EID: 0042808525     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(03)01005-7     Document Type: Article

References (188)

1. M Adams M.J Reginato D Shao M.A Lazar V.K Chatterjee Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site J. Biol. Chem. 272 1997 5128 5132
2. C Aperlo P Pognonec R Saladin J Auwerx K.E Boulukos cDNA cloning and characterization of the transcriptional activities of the hamster peroxisome proliferator-activated receptor haPPAR γ Gene 162 1995 297 302
3. M Asakawa H Takano T Nagai H Uozumi H Hasegawa N Kubota T Saito Y Masuda T Kadowaki I Komuro Peroxisome proliferator-activated receptor γ plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo Circulation 105 2002 1240 1246
4. V.R Babaev A.S Major T Zhu I Hiroyuki D.E Dove S Fazio M.F Linto C.F Semenkovich Macrophage expression of PPARα inhibits atherosclerotic lesion formation in LDL-receptor deficient mice Circulation 104 2001 45 46
5. Y Barak M.C Nelson E.S Ong Y.Z Jones P Ruiz-Lozano K.R Chien A Koder R.M Evans PPAR γ is required for placental, cardiac, and adipose tissue development Mol. Cell. 4 1999 585 595
6. Y Barak D Liao W He E.S Ong M.C Nelson J.M Olefsky R Boland R.M Evans Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer Proc. Natl. Acad. Sci. USA 99 2002 303 308
7. O Barbier I.P Torra Y Duguay C Blanquart J.C Fruchart C Glineur B Staels Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis Arterioscler. Thromb. Vasc. Biol. 22 2002 717 726
8. I Barroso M Gurnell V.E.F Crowley M Agostini J.W Schwabe M.A Soos G.L Maslen T.D.M Williams H Lewis A.J Schafer V.K.K Chatterjee S O'Rahilly Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension Nature 401 1999 880 883
9. B.A Beamer C.J Yen R.E Andersen D Muller D Elahi L.J Cheskin R Andres J Roth A.R Shuldiner Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations Diabetes 47 1998 1806 1808
10. A.R Bell R Savory N.J Horley A.I Choudhury M Dickins T.J Gray A.M Salter D.R Bell Molecular basis of non-responsiveness to peroxisome proliferators: The guinea-pig PPARα is functional and mediates peroxisome proliferator-induced hypolipidaemia Biochem. J. 332 1998 689 693
11. S Benson J Wu S Padmanabhan T.W Kurtz H.A Pershadsingh Peroxisome proliferator-activated receptor (PPAR)-γ expression in human vascular smooth muscle cells: Inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-γ activator troglitazone Am. J. Hypertens. 13 2000 74 82
12. J Berger D.E Moller The mechanisms of action of PPARs Annu. Rev. Med. 53 2002 409 435
13. E Biesiada M Razandi E.R Levin Egr-1 activates basic fibroblast growth factor transcription: Mechanistic implications for astrocyte proliferation J. Biol. Chem. 271 1996 18576 18581
14. D Bishop-Bailey T Hla T.D Warner Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-γ ligand therapy Circ. Res. 91 2002 210 217
15. C Blanquart O Barbier J.C Fruchart B Staels C Glineur Peroxisome proliferator-activated receptor α (PPARα) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes J. Biol. Chem. 277 2002 37254 37259
16. 2-cholesterol response of abdominally obese men treated with gemfibrozil Genet. Med. 4 2002 311 315
17. P.J Brown T.A Smith-Oliver P.S Charifson N.C Tomkinson A.M Fivush D.D Sternbach L.E Wade L Orband-Miller D.J Parks S.G Blanchard S.A Kliewer J.M Lehmann T.M Willson Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library Chem. Biol. 4 1997 909 918
18. P.J Brown D.A Winegar K.D Plunket L.B Moore M.C Lewis J.G Wilson S.S Sundseth C.S Koble Z Wu J.M Chapman J.M Lehmann S.A Kliewer T.M Willson A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARα agonist with potent lipid-lowering activity J. Med. Chem. 42 1999 3785 3788
19. F.M Campbell R Kozak A Wagner J.Y Altarejos J.R Dyck D.D Belke D.L Severson D.P Kelly G.D Lopaschuk A role for peroxisome proliferator-activated receptor α (PPARα) in the control of cardiac malonyl-CoA levels: Reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARα are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase J. Biol. Chem. 277 2002 4098 4103
20. A Chawla Y Barak L Nagy D Liao P Tontonoz R.M Evans PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation Nat. Med. 7 2001 48 52
21. N.G Chen X Han Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium Biochem. Biophys. Res. Commun. 282 2001 717 722
22. Z Chen S Ishibashi S Perrey J.i Osuga T Gotoda T Kitamine Y Tamura H Okazaki N Yahagi Y Iizuka F Shionoiri K Ohashi K Harada H Shimano R Nagai N Yamada Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: Pleiotropic effects on CD36 expression and HDL Arterioscler. Thromb. Vasc. Biol. 21 2001 372 377
23. G Chinetti S Lestavel V Bocher A.T Remaley B Neve I.P Torra E Teissier A Minnich M Jaye N Duverger H.B Brewer J.C Fruchart V Clavey B Staels PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway Nat. Med. 7 2001 53 58
24. A.R Collins W.P Meehan U Kintscher S Jackson S Wakino G Noh W Palinski W.A Hsueh R.E Law Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice Arterioscler. Thromb. Vasc. Biol. 21 2001 365 371
25. S.A Cook T Matsui L Li A Rosenzweig Transcriptional effects of chronic Akt activation in the heart J. Biol. Chem. 277 2002 22528 22533
26. S.S Deeb L Fajas M Nemoto J Pihlajamaki J Kuusisto M Laakso W Fujimoto J Auwerx A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity Nat. Genet. 20 1998 284 287
27. P Delerive K De Bosscher S Besnard W Vanden Berghe J.M Peters F.J Gonzalez J.C Fruchart A Tedgui G Haegeman B Staels Peroxisome proliferator-activated receptor α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1 J. Biol. Chem. 274 1999 32048 32054
28. P Delerive F Martin-Nizard G Chinetti F Trottein J.C Fruchart J Najib P Duriez B Staels Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway Circ. Res. 85 1999 394 402
29. P Delerive P Gervois J.C Fruchart B Staels Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators J. Biol. Chem. 275 2000 36703 36707
30. B Desvergne W Wahli Peroxisome proliferator-activated receptors: Nuclear control of metabolism Endocr. Rev. 20 1999 649 688
31. 4 pathway to inflammation control Nature 384 1996 39 43
32. 4 J. Biol. Chem. 274 1999 23341 23348
33. Q.N Diep M El Mabrouk J.S Cohn D Endemann F Amiri A Virdis M.F Neves E.L Schiffrin Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: Role of peroxisome proliferator-activated receptor-γ Circulation 105 2002 2296 2302
34. S.T Ding R.L McNeel H.J Mersmann Expression of porcine adipocyte transcripts: Tissue distribution and differentiation in vitro and in vivo Comp. Biochem. Physiol. B Biochem. Mol. Biol. 123 1999 307 318
35. C Dreyer G Krey H Keller F Givel G Helftenbein W Wahli Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors Cell 68 1992 879 887
36. P Escher O Braissant S Basu-Modak L Michalik W Wahli B Desvergne Rat PPARs: Quantitative analysis in adult rat tissues and regulation in fasting and refeeding Endocrinology 142 2001 4195 4202
37. D Evans J Aberle D Wendt A Wolf U Beisiegel W.A Mann A polymorphism, L162V, in the peroxisome proliferator-activated receptor α (PPARα) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus J. Mol. Med. 79 2001 198 204
38. L Fajas D Auboeuf E Raspe K Schoonjans A.M Lefebvre R Saladin J Najib M Laville J.C Fruchart S Deeb A Vidal-Puig J Flier M.R Briggs B Staels H Vidal J Auwerx The organization, promoter analysis, and expression of the human PPARγ gene J. Biol. Chem. 272 1997 18779 18789
39. L Fajas J.C Fruchart J Auwerx PPARγ3 mRNA: A distinct PPARγ mRNA subtype transcribed from an independent promoter FEBS Lett. 438 1998 55 60
40. B.N Finck J.J Lehman T.C Leone M.J Welch M.J Bennett A Kovacs X Han R.W Gross R Kozak G.D Lopaschuk D.P Kelly The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus J. Clin. Invest. 109 2002 121 130
41. D.M Flavell Y Jamshidi E Hawe Pineda I Torra M.R Taskinen M.H Frick M.S Nieminen Y.A Kesaniemi A Pasternack B Staels G Miller S.E Humphries P.J Talmud M Syvanne Peroxisome proliferator-activated receptor α gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease Circulation 105 2002 1440 1445
42. 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR γ Cell 83 1995 803 812
43. B.M Forman J Chen R.M Evans Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ Proc. Natl. Acad. Sci. USA 94 1997 4312 4317
44. M Fu J Zhang X Zhu D.E Myles T.M Willson X Liu Y.E Chen Peroxisome proliferator-activated receptor γ inhibits transforming growth factor β-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3 J. Biol. Chem. 276 2001 45888 45894
45. M Fu X Zhu Q Wang J Zhang Q Song H Zheng W Ogawa J Du Y.E Chen Platelet-derived growth factor promotes the expression of peroxisome proliferator-activated receptor γ in vascular smooth muscle cells by a phosphatidylinositol 3-kinase⧸Akt signaling pathway Circ. Res. 89 2001 1058 1064
46. M Fu J Zhang Y Lin X Zhu M.U Ehrengruber Y.E Chen Early growth response factor-1 is a critical transcriptional mediator of peroxisome proliferator-activated receptor-γ 1 gene expression in human aortic smooth muscle cells J. Biol. Chem. 277 2002 26808 26814
47. M Fu J Zhang Y Lin X Zhu T.M Willson Y.E Chen Activation of peroxisome proliferator-activated receptor γ inhibits osteoprotegerin gene expression in human aortic smooth muscle cells Biochem. Biophys. Res. Commun. 294 2002 597 601
48. Y Fukunaga H Itoh K Doi T Tanaka J Yamashita T.H Chun M Inoue K Masatsugu N Sawada T Saito K Hosoda H Kook M Ueda K Nakao Thiazolidinediones, peroxisome proliferator-activated receptor γ agonists, regulate endothelial cell growth and secretion of vasoactive peptides Atherosclerosis 158 2001 113 119
49. K Ge M Guermah C.X Yuan M Ito A.E Wallberg B.M Spiegelman R.G Roeder Transcription coactivator TRAP220 is required for PPAR γ 2-stimulated adipogenesis Nature 417 2002 563 567
50. L Gelman G Zhou L Fajas E Raspe J.C Fruchart J Auwerx p300 interacts with the N- and C-terminal part of PPARγ2 in a ligand-independent and -dependent manner, respectively J. Biol. Chem. 274 1999 7681 7688
51. P Gervois N Vu-Dac R Kleemann M Kockx G Dubois B Laine V Kosykh J.C Fruchart T Kooistra B Staels Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor α agonists via inhibition of CCAAT box⧸enhancer-binding protein β J. Biol. Chem. 276 2001 33471 33477
52. M.N Ghazzi J.E Perez T.K Antonucci J.H Driscoll S.M Huang B.W Faja R.W Whitcomb Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group Diabetes 46 1997 433 439
53. S Goetze U Kintscher S Kim W.P Meehan K Kaneshiro A.R Collins E Fleck W.A Hsueh R.E Law Peroxisome proliferator-activated receptor-γ ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase⧸mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration J. Cardiovasc. Pharmacol. 38 2001 909 921
54. M Gottlicher E Widmark Q Li J.A Gustafsson Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor Proc. Natl. Acad. Sci. USA 89 1992 4653 4657
55. M.E Greene B Blumberg O.W McBride H.F Yi K Kronquist K Kwan L Hsieh G Greene S.D Nimer Isolation of the human peroxisome proliferator activated receptor γ cDNA: Expression in hematopoietic cells and chromosomal mapping Gene Expr. 4 1995 281 299
56. H.M Guardiola-Diaz S Rehnmark N Usuda T Albrektsen D Feltkamp J.A Gustafsson S.E Alexson Rat peroxisome proliferator-activated receptors and brown adipose tissue function during cold acclimatization J. Biol. Chem. 274 1999 23368 23377
57. R.A Gupta J Tan W.F Krause M.W Geraci T.M Willson S.K Dey R.N DuBois Prostacyclin-mediated activation of peroxisome proliferator-activated receptor δ in colorectal cancer Proc. Natl. Acad. Sci. USA 97 2000 13275 13280
58. T Hamano K Kobayashi T Sakairi M Hayashi M Mutai Peroxisome proliferator-activated receptor α (PPARα) agonist, WY-14,643, increased transcription of myosin light chain-2 in cardiomyocytes J. Toxicol. Sci. 26 2001 275 284
59. K.H Han M.K Chang A Boullier S.R Green A Li C.K Glass O Quehenberger Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor γ J. Clin. Invest. 106 2000 793 802
60. J.B Hansen H Zhang T.H Rasmussen R.K Petersen E.N Flindt K Kristiansen Peroxisome proliferator-activated receptor δ (PPARδ)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling J. Biol. Chem. 276 2001 3175 3182
61. C.M Hao R Redha J Morrow M.D Breyer Peroxisome proliferator-activated receptor delta activation promotes cell survival following hypertonic stress J. Biol. Chem. 277 2002 21341 21345
62. S.J Hasstedt Q.F Ren K Teng S.C Elbein Effect of the peroxisome proliferator-activated receptor-γ-2 Pro12Ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds J. Clin. Endocrinol. Metab. 86 2001 536 541
63. Y Hattori S Hattori K Kasai Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells Hypertension 33 1999 943 948
64. S Hauser G Adelmant P Sarraf H.M Wright E Mueller B.M Spiegelman Degradation of the peroxisome proliferator-activated receptor γ is linked to ligand-dependent activation J. Biol. Chem. 275 2000 18527 18533
65. K Hayashida N Kume M Minami H Kataoka M Morimoto T Kita Peroxisome proliferator-activated receptor α ligands increase lectin-like oxidized low density lipoprotein receptor-1 expression in vascular endothelial cells Ann. N.Y. Acad. Sci. 947 2001 370 372
66. T.C He T.A Chan B Vogelstein K.W Kinzler PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs Cell 99 1999 335 345
67. K Hotta T.A Gustafson S Yoshioka H.K Ortmeyer N.L Bodkin B.C Hansen Relationships of PPARγ and PPARγ2 mRNA levels to obesity, diabetes and hyperinsulinaemia in rhesus monkeys Int. J. Obes. Relat. Metab. Disord. 22 1998 1000 1010
68. D Hourton P Delerive J Stankova B Staels M.J Chapman E Ninio Oxidized low-density lipoprotein and peroxisome-proliferator-activated receptor α down-regulate platelet-activating-factor receptor expression in human macrophages Biochem. J. 354 2001 225 232
69. C.J Hupfeld R.H Weiss TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27 Am. J. Physiol. Endocrinol. Metab. 281 2001 E207 E216
70. U Ikeda M Shimpo Y Murakami K Shimada Peroxisome proliferator-activated receptor-γ ligands inhibit nitric oxide synthesis in vascular smooth muscle cells Hypertension 35 2000 1232 1236
71. Y Ikeda A Sugawara Y Taniyama A Uruno K Igarashi S Arima S Ito K Takeuchi Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator-activated receptor γ in macrophages via an interaction with NRF2 J. Biol. Chem. 275 2000 33142 33150
72. H Inoue T Tanabe K Umesono Feedback control of cyclooxygenase-2 expression through PPARγ J. Biol. Chem. 275 2000 28028 28032
73. I Inoue K Shino S Noji T Awata S Katayama Expression of peroxisome proliferator-activated receptor α (PPAR α) in primary cultures of human vascular endothelial cells Biochem. Biophys. Res. Commun. 246 1998 370 374
74. I Inoue S Goto K Mizotani T Awata T Mastunaga S Kawai T Nakajima S Hokari T Komoda S Katayama Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: Reduction of MRNA levels for interleukin-1β interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor α (PPARα) in primary endothelial cells Life Sci. 67 2000 863 876
75. 2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells Metabolism 50 2001 3 11
76. M Inoue H Itoh T Tanaka T.H Chun K Doi Y Fukunaga N Sawada J Yamshita K Masatsugu T Saito S Sakaguchi M Sone K.i Yamahara T Yurugi K Nakao Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-γ Arterioscler. Thromb. Vasc. Biol. 21 2001 560 566
77. I Issemann S Green Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 347 1990 645 650
78. S.M Jackson F Parhami X.P Xi J.A Berliner W.A Hsueh R.E Law L.L Demer Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte–endothelial cell interaction Arterioscler. Thromb. Vasc. Biol. 19 1999 2094 2104
79. Y Jamshidi H.E Montgomery H.W Hense S.G Myerson I.P Torra B Staels M.J World A Doering J Erdmann C Hengstenberg S.E Humphries H Schunkert D.M Flavell Peroxisome proliferator-activated receptor α gene regulates left ventricular growth in response to exercise and hypertension Circulation 105 2002 950 955
80. C Jehl-Pietri C Bastie I Gillot S Luquet P.A Grimaldi Peroxisome-proliferator-activated receptor δ mediates the effects of long-chain fatty acids on post-confluent cell proliferation Biochem J. 350 2000 93 98
81. C Jiang A.T Ting B Seed PPAR-γ agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
82. C.E Juge-Aubry E Hammar C Siegrist-Kaiser A Pernin A Takeshita W.W Chin A.G Burger C.A Meier Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor α by phosphorylation of a ligand-independent trans-activating domain J. Biol. Chem. 274 1999 10505 10510
83. K Kato H Satoh Y Endo D Yamada S Midorikawa W Sato K Mizuno T Fujita K Tsukamoto T Watanabe Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARγ in endothelial function Biochem. Biophys. Res. Commun. 258 1999 431 435
84. J Kawasaki K Hirano J Nishimura M Fujishima H Kanaide Mechanisms of vasorelaxation induced by troglitazone, a novel antidiabetic drug, in the porcine coronary artery Circulation 98 1998 2446 2452
85. S Kersten B Desvergne W Wahli Roles of PPARs in health and disease Nature 405 2000 421 424
86. L.M Khachigian V Lindner A.J Williams T Collins Egr-1-induced endothelial gene expression: A common theme in vascular injury Science 271 1996 1427 1431
87. L.M Khachigian K.R Anderson N.J Halnon M.A Gimbrone Jr. N Resnick T Collins Egr-1 is activated in endothelial cells exposed to fluid shear stress and interacts with a novel shear-stress-response element in the PDGF A-chain promoter Arterioscler. Thromb. Vasc. Biol. 17 1997 2280 2286
88. 2-terminal kinase⧸activating protein 1 pathway and protects the heart from ischemia⧸reperfusion injury Diabetes 51 2002 1507 1514
89. S.A Kliewer K Umesono D.J Noonan R.A Heyman R.M Evans Convergence of 9- cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors Nature 358 1992 771 774
90. S.A Kliewer B.M Forman B Blumberg E.S Ong U Borgmeyer D.J Mangelsdorf K Umesono R.M Evans Differential expression and activation of a family of murine peroxisome proliferator-activated receptors Proc. Natl. Acad. Sci. USA 91 1994 7355 7359
91. S.A Kliewer J.M Lenhard T.M Willson I Patel D.C Morris J.M Lehmann A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation Cell 83 1995 813 819
92. S.A Kliewer S.S Sundseth S.A Jones P.J Brown G.B Wisely C.S Koble P Devchand W Wahli T.M Willson J.M Lenhard J.M Lehmann Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ Proc. Natl. Acad. Sci. USA 94 1997 4318 4323
93. R Komers A Vrana Thiazolidinediones—tools for the research of metabolic syndrome X Physiol. Res. 47 1998 215 225
94. N Kubota Y Terauchi H Miki H Tamemoto T Yamauchi K Komeda S Satoh R Nakano C Ishii T Sugiyama K Eto Y Tsubamoto A Okuno K Murakami H Sekihara G Hasegawa M Naito Y Toyoshima S Tanaka K Shiota T Kitamura T Fujita O Ezaki S Aizawa T Kadowaki PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance Mol. Cell. 4 1999 597 609
95. B.R Kwak S Myit F Mulhaupt N Veillard N Rufer E Roosnek F Mach PPARγ but not PPARα ligands are potent repressors of major histocompatibility complex class II induction in atheroma-associated cells Circ. Res. 90 2002 356 362
96. C Lacquemant F Lepretre Torra.I Pineda M Manraj G Charpentier J Ruiz B Staels P Froguel Mutation screening of the PPARα gene in type 2 diabetes associated with coronary heart disease Diabetes Metab. 26 2000 393 401
97. R.E Law W.P Meehan X.P Xi K Graf D.A Wuthrich W Coats D Faxon W.A Hsueh Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia J. Clin. Invest. 98 1996 1897 1905
98. R.E Law S Goetze X.P Xi S Jackson Y Kawano L Demer M.C Fishbein W.P Meehan W.A Hsueh Expression and function of PPARγ in rat and human vascular smooth muscle cells Circulation 101 2000 1311 1318
99. M.A Lazar Progress in cardiovascular biology: PPAR for the course Nat. Med. 7 2001 23 24
100. H Lee W Shi P Tontonoz S Wang G Subbanagounder C.C Hedrick S Hama C Borromeo R.M Evans J.A Berliner L Nagy Role for peroxisome proliferator-activated receptor α in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells Circ. Res. 87 2000 516 521
101. S.S Lee T Pineau J Drago E.J Lee J.W Owens D.L Kroetz P.M Fernandez-Salguero H Westphal F.J Gonzalez Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators Mol. Cell. Biol. 15 1995 3012 3022
102. M.D Leibowitz C Fievet N Hennuyer J Peinado-Onsurbe H Duez J Bergera C.A Cullinan C.P Sparrow J Baffic G.D Berger C Santini R.W Marquis R.L Tolman R.G Smith D.E Moller J Auwerx Activation of PPARδ alters lipid metabolism in db ⧸ db mice FEBS Lett. 473 2000 333 336
103. T Lemberger O Braissant C Juge-Aubry H Keller R Saladin B Staels J Auwerx A.G Burger C.A Meier W Wahli PPAR tissue distribution and interactions with other hormone-signaling pathways Ann. N.Y. Acad. Sci. 804 1996 231 251
104. A.C Li K.K Brown M.J Silvestre T.M Willson W Palinski C.K Glass Peroxisome proliferator-activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor-deficient mice J. Clin. Invest. 106 2000 523 531
105. P Libby U Schoenbeck F Mach A.P Selwyn P Ganz Current concepts in cardiovascular pathology: The role of LDL cholesterol in plaque rupture and stabilization Am. J. Med. 104 1998 14S 18S
106. H Lim R.A Gupta W.G Ma B.C Paria D.E Moller J.D Morrow R.N DuBois J.M Trzaskos S.K Dey Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ Genes Dev. 13 1999 1561 1574
107. J.M Maglich A Sluder X Guan Y Shi D.D McKee K Carrick K Kamdar T.M Willson J.T Moore Comparison of complete nuclear receptor sets from the human, Caenorhabditis elegans and Drosophila genomes Genome Biol. 2 2001 RESEARCH0029.1–0029.7
108. F.P Mancini O Vaccaro L Sabatino A Tufano A.A Rivellese G Riccardi V Colantuoni Pro12Ala substitution in the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes Diabetes 48 1999 1466 1468
109. H Mano C Kimura Y Fujisawa T Kameda M Watanabe-Mano H Kaneko T Kaneda Y Hakeda M Kumegawa Cloning and function of rabbit peroxisome proliferator-activated receptor δ⧸β in mature osteoclasts J. Biol. Chem. 275 2000 8126 8132
110. N Marx U Schonbeck M.A Lazar P Libby J Plutzky Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells Circ. Res. 83 1998 1097 1103
111. N Marx G Sukhova C Murphy P Libby J Plutzky Macrophages in human atheroma contain PPARγ: Differentiation-dependent peroxisomal proliferator-activated receptor γ (PPARγ) expression and reduction of MMP-9 activity through PPARγ activation in mononuclear phagocytes in vitro Am. J. Pathol. 153 1998 17 23
112. N Marx T Bourcier G.K Sukhova P Libby J Plutzky PPARγ activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARγ as a potential mediator in vascular disease Arterioscler. Thromb. Vasc. Biol. 19 1999 546 551
113. N Marx G.K Sukhova T Collins P Libby J Plutzky PPARα activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells Circulation 99 1999 3125 3131
114. N Marx F Mach A Sauty J.H Leung M.N Sarafi R.M Ransohoff P Libby J Plutzky A.D Luster Peroxisome proliferator-activated receptor-γ activators inhibit IFN-γ-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells J. Immunol. 164 2000 6503 6508
115. N Marx N Mackman U Schonbeck N Yilmaz V.V Hombach P Libby J Plutzky PPARα activators inhibit tissue factor expression and activity in human monocytes Circulation 103 2001 213 219
116. N Marx B Kehrle K Kohlhammer M Grub W Koenig V Hombach P Libby J Plutzky PPAR activators as antiinflammatory mediators in human T lymphocytes: Implications for atherosclerosis and transplantation-associated arteriosclerosis Circ. Res. 90 2002 703 710
117. K Matsumoto K Hirano S Nozaki A Takamoto M Nishida Y Nakagawa-Toyama M.Y Janabi T Ohya S Yamashita Y Matsuzawa Expression of macrophage (Mφ) scavenger receptor, CD36, in cultured human aortic smooth muscle cells in association with expression of peroxisome proliferator activated receptor-γ, which regulates gain of Mφ-like phenotype in vitro, and its implication in atherogenesis Arterioscler. Thromb. Vasc. Biol. 20 2000 1027 1032
118. M Mehrabian J Wong X Wang Z Jiang W Shi A.M Fogelman A.J Lusis Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia Circ. Res. 89 2001 125 130
119. A Meirhaeghe L Fajas N Helbecque D Cottel P Lebel J Dallongeville S Deeb J Auwerx P.A Amouyel Genetic polymorphism of the peroxisome proliferator-activated receptor γ gene influences plasma leptin levels in obese humans Hum. Mol. Genet. 7 1998 435 440
120. P.D Miles Y Barak W He R.M Evans J.M Olefsky Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency J. Clin. Invest. 105 2000 287 292
121. J Minamikawa S Tanaka M Yamauchi D Inoue H Koshiyama Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes J. Clin. Endocrinol. Metab. 83 1998 1818 1820
122. 1 arrest and differentiation marker expression in vascular smooth muscle cells Mol. Pharmacol. 58 2000 837 844
123. K.J Moore E.D Rosen M.L Fitzgerald F Randow L.P Andersson D Altshuler D.S Milstone R.M Mortensen B.M Spiegelman M.W Freeman The role of PPAR-γ in macrophage differentiation and cholesterol uptake Nat. Med. 7 2001 41 47
124. L Nagy P Tontonoz J.G Alvarez H Chen R.M Evans Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ Cell 93 1998 229 240
125. T Nawa M.T Nawa Y Cai C Zhang I Uchimura S Narumi F Numano S Kitajima Repression of TNF-α-induced E-selectin expression by PPAR activators: Involvement of transcriptional repressor LRF-1⧸ATF3 Biochem. Biophys. Res. Commun. 275 2000 406 411
126. B.P Neve D Corseaux G Chinetti C Zawadzki J.C Fruchart P Duriez B Staels B Jude PPARα agonists inhibit tissue factor expression in human monocytes and macrophages Circulation 103 2001 207 212
127. J.J Nolan B Lidvik P Beerdsen M Joyce J.M Olefsky Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone N. Engl. J. Med. 331 1994 1188 1193
128. T Ogata T Miyauchi S Sakai Y Irukayama-Tomobe K Goto I Yamaguchi Stimulation of peroxisome-proliferator-activated receptor α (PPARα) attenuates cardiac fibrosis and endothelin-1 production in pressure-overloaded rat hearts Clin. Sci. 103 2002 284S 288S
129. T Ogihara H Rakugi H Ikegami H Mikami K Masuo Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives Am. J. Hypertens. 8 1995 316 320
130. W.R Oliver Jr. J.L Shenk M.R Snaith C.S Russell K.D Plunket N.L Bodkin M.C Lewis D.A Winegar M.L Sznaidman M.H Lambert H.E Xu D.D Sternbach S.A Kliewer B.C Hansen T.M Willson A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport Proc. Natl. Acad. Sci. USA 98 2001 5306 5311
131. Y Oyama N Akuzawa R Nagai M Kurabayashi PPARγ ligand inhibits osteopontin gene expression through interference with binding of nuclear factors to A⧸T-rich sequence in THP-1 cells Circ. Res. 90 2002 348 355
132. B.H Park B Vogelstein K.W Kinzler Genetic disruption of PPARδ decreases the tumorigenicity of human colon cancer cells Proc. Natl. Acad. Sci. USA 98 2001 2598 2603
133. L Patel I Pass P Coxon C Downes S.A Smith C.H Macphee Tumor suppressor and anti-inflammatory actions of PPARγ agonists are mediated via upregulation of PTEN Curr. Biol. 11 2001 764 768
134. V Pasceri J.S Cheng J.T Willerson E.T Yeh J Chang Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs Circulation 101 2000 235 238
135. J.M Peters S.S Lee W Li J.M Ward O Gavrilova C Everett M.L Reitman L.D Hudson F.J Gonzalez Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor β(δ) Mol. Cell. Biol. 20 2000 5119 5128
136. H Poirier I Niot M.C Monnot O Braissant C Meunier-Durmort P Costet T Pineau W Wahli T.M Willson P Besnard Differential involvement of peroxisome-proliferator-activated receptors α and δ in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine Biochem. J. 355 2001 481 488
137. M Ricote A.C Li T.M Willson C.J Kelly C.K Glass The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation Nature 391 1998 79 82
138. M Ristow D Muller-Wieland W Krone C.R Kahn Obesity associated with a mutation in a genetic regulator of adipocyte differentiation N. Engl. J. Med. 339 1998 953 959
139. Y Rival N Beneteau T Taillandier M Pezet E Dupont-Passelaigue J.F Patoiseau D Junquero F.C Colpaert A Delhon PPARα and PPARδ activators inhibit cytokine-induced nuclear translocation of NF-κB and expression of VCAM-1 in EAhy926 endothelial cells Eur. J. Pharmacol. 435 2002 143 151
140. S.J Robins PPARα ligands and clinical trials: Cardiovascular risk reduction with fibrates J. Cardiovasc. Risk. 8 2001 195 201
141. E.D Rosen P Sarraf A.E Troy G Bradwin K Moore D.S Milstone B.M Spiegelman R.M Mortensen PPAR γ is required for the differentiation of adipose tissue in vivo and in vitro Mol. Cell. 4 1999 611 617
142. M.G Rosenfeld C.K Glass Coregulator codes of transcriptional regulation by nuclear receptors J. Biol. Chem. 276 2001 36865 36868
143. R Ross Atherosclerosis—an inflammatory disease N. Engl. J. Med. 340 1999 115 126
144. A Rossi P Kapahi G Natoli T Takahashi Y Chen M Karin M.G Santoro Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase Nature 403 2000 103 108
145. B Ruyter O Andersen A Dehli Ostlund A.K Farrants T Gjoen M.S Thomassen Peroxisome proliferator activated receptors in Atlantic salmon ( Salmo salar ): Effects on PPAR transcription and acyl-CoA oxidase activity in hepatocytes by peroxisome proliferators and fatty acids Biochim. Biophys. Acta. 1348 1997 331 338
146. M.N Sack T.A Rader S Park J Bastin S.A McCune D.P Kelly Fatty acid oxidation enzyme gene expression is downregulated in the failing heart Circulation 94 1996 2837 2842
147. H Satoh K Tsukamoto Y Hashimoto N Hashimoto M Togo M Hara H Maekawa N Isoo S Kimura T Watanabe Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: A new possible role of PPAR on vascular endothelial function Biochem. Biophys. Res. Commun. 254 1999 757 763
148. A Schmidt N Endo S.J Rutledge R Vogel D Shinar G.A Rodan Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids Mol. Endocrinol. 6 1992 1634 1641
149. T Sher H.F Yi O.W McBride F.J Gonzalez cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor Biochemistry 32 1993 5598 5604
150. Y Shi M Hon R.M Evans The peroxisome proliferator-activated receptor δ, an integrator of transcriptional repression and nuclear receptor signaling Proc. Natl. Acad. Sci. USA 99 2002 2613 2618
151. E.S Silverman T Collins Pathways of Egr-1-mediated gene transcription in vascular biology Am. J. Pathol. 154 1999 665 670
152. C Skerka E.L Decker P.F Zipfel A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 J. Biol. Chem. 270 1995 22500 22506
153. J Skogsberg K Kannisto L Roshani E Gagne A Hamsten C Larsson E Ehrenborg Characterization of the human peroxisome proliferator activated receptor δ gene and its expression Int. J. Mol. Med. 6 2000 73 81
154. 2+ current and not endothelial nitric oxide production Diabetes 46 1997 659 664
155. N Sparano T.L Seaton Troglitazone in type II diabetes mellitus Pharmacotherapy 18 1998 539 548
156. B Staels W Koenig A Habib R Merval M Lebret I.P Torra P Delerive A Fadel G Chinetti J.C Fruchart J Najib J Maclouf A Tedgui Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators Nature 393 1998 790 793
157. C.M Steppan S.T Bailey S Bhat E.J Brown R.R Banerjee C.M Wright H.R Patel R.S Ahima M.A Lazar The hormone resistin links obesity to diabetes Nature 409 2001 307 312
158. 12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway Proc. Natl. Acad. Sci. USA 97 2000 4844 4849
159. M Stumvoll H Haring The peroxisome proliferator-activated receptor-γ2 Pro12Ala polymorphism Diabetes 51 2002 2341 2347
160. A Sugawara K Takeuchi A Uruno Y Ikeda S Arima M Kudo K Sato Y Taniyama S Ito Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-γ in vascular smooth muscle cells Endocrinology 142 2001 3125 3134
161. A Sugawara A Uruno M Kudo Y Ikeda K Sato Y Taniyama S Ito K Takeuchi Transcription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-γ via an interaction with Sp1 in vascular smooth muscle cells J. Biol. Chem. 277 2002 9676 9683
162. B.H Sung J.L., Jr Izzo P Dandona M.F Wilson Vasodilatory effects of troglitazone improve blood pressure at rest during mental stress in type 2 diabetes mellitus Hypertension 34 1999 83 88
163. C.J Tack M.K Ong J.A Lutterman P Smits Insulin-induced vasodilatation and endothelial function in obesity⧸insulin resistance: Effects of troglitazone Diabetologia 41 1998 569 576
164. I Takada R.T Yu H.E Xu M.H Lambert V.G Montana S.A Kliewer R.M Evans K Umesono Alteration of a single amino acid in peroxisome proliferator-activated receptor-α (PPAR α) generates a PPAR δ phenotype Mol. Endocrinol. 14 2000 733 740
165. H Takano T Nagai M Asakawa T Toyozaki T Oka I Komuro T Saito Y Masuda Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-α expression in neonatal rat cardiac myocytes Circ. Res. 87 2000 596 602
166. Y Takata Y Kitami T Okura K Hiwada Peroxisome proliferator-activated receptor-γ activation inhibits interleukin-1β-mediated platelet-derived growth factor-α receptor gene expression via CCAAT⧸enhancer-binding protein-δ in vascular smooth muscle cells J. Biol. Chem. 276 2001 12893 12897
167. K Takeda T Ichiki T Tokunou Y Funakoshi N Iino K Hirano H Kanaide A Takeshita Peroxisome proliferator-activated receptor γ activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells Circulation 102 2000 1834 1839
168. 2 integrin-dependent oxidative burst: Involvement of a mechanism distinct from peroxisome proliferator-activated receptor γ ligation J. Immunol. 163 1999 6187 6192
169. R Valve K Sivenius R Miettinen J Pihlajamaki A Rissanen S.S Deeb J Auwerx M Uusitupa M Laakso Two polymorphisms in the peroxisome proliferator-activated receptor-γ gene are associated with severe overweight among obese women J. Clin. Endocrinol. Metab. 84 1999 3708 3712
170. M.C Vohl P Lepage D Gaudet C.G Brewer C Betard P Perron G Houde C Cellier J.M Faith J.P Despres K Morgan T.J Hudson Molecular scanning of the human PPARα gene: Association of the L162V mutation with hyperapobetalipoproteinemia J. Lipid Res. 41 2000 945 952
171. H Vosper L Patel T.L Graham G.A Khoudoli A Hill C.H Macphee I Pinto S.A Smith K.E Suckling C.R Wolf C.N Palmer The peroxisome proliferator-activated receptor δ promotes lipid accumulation in human macrophages J. Biol. Chem. 276 2001 44258 44265
172. 1→S transition in vascular smooth muscle cells J. Biol. Chem. 275 2000 22435 22441
173. Cip1 by modulating the protein kinase Cδ pathway in vascular smooth muscle cells J. Biol. Chem. 276 2001 47650 47657
174. X.L Wang J Oosterhof N Duarte Peroxisome proliferator-activated receptor C161 → T polymorphism and coronary artery disease Cardiovasc. Res. 44 1999 588 594
175. N.S Wayman Y Hattori M.C McDonald H Mota-Filipe S Cuzzocrea B Pisano P.K Chatterjee C Thiemermann Ligands of the peroxisome proliferator-activated receptors (PPAR-γ and PPAR-α) reduce myocardial infarct size FASEB J. 16 2002 1027 1040
176. T.M Willson P.J Brown D.D Sternbach B.R Henke The PPARs: From orphan receptors to drug discovery J. Med. Chem. 43 2000 527 550
177. X Xin S Yang J Kowalski M.E Gerritsen Peroxisome proliferator-activated receptor γ ligands are potent inhibitors of angiogenesis in vitro and in vivo J. Biol. Chem. 274 1999 9116 9121
178. G Xing L Zhang L Zhang T Heynen T Yoshikawa M Smith S Weiss S Detera-Wadleigh Rat PPAR δ contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei Biochem. Biophys. Res. Commun. 217 1995 1015 1025
179. K Yamakawa M Hosoi H Koyama S Tanaka S Fukumoto H Morii Y Nishizawa Peroxisome proliferator-activated receptor-γ agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells Biochem. Biophys. Res. Commun. 271 2000 571 574
180. J Yao N Mackman T.S Edgington S.T Fan Lipopolysaccharide induction of the tumor necrosis factor-α promoter in human monocytic cells: Regulation by Egr-1, c-Jun, and NF-κ B transcription factors J. Biol. Chem. 272 1997 17795 17801
181. C.J Yen B.A Beamer C Negri K Silver K.A Brown D.P Yarnall D.K Burns J Roth A.R Shuldiner Molecular scanning of the human peroxisome proliferator activated receptor γ gene in diabetic Caucasians: Identification of a Pro12Ala PPAR-γ-2 missense mutation Biochem. Biophys. Res. Commun. 241 1997 270 274
182. T Yokomizo T Izumi K Chang Y Takuwa T Shimizu A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis Nature 387 1997 620 624
183. T.L Yue J Chen W Bao P.K Narayanan A Bril W Jiang P.G Lysko J.L Gu R Boyce D.M Zimmerman T.K Hart R.E Buckingham E.H Ohlstein In vivo myocardial protection from ischemia⧸reperfusion injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone Circulation 104 2001 2588 2594
184. J Zhang M Fu X Zhu Y Xiao Y Mou H Zheng M.A Akinbami Q Wang Y.E Chen Peroxisome proliferator-activated receptor δ is up-regulated during vascular lesion formation and promotes post-confluent cell proliferation in vascular smooth muscle cells J. Biol. Chem. 277 2002 11505 11512
185. J Zhou K.M Wilson J.D Medh Genetic analysis of four novel peroxisome proliferator activated receptor-γ splice variants in monkey macrophages Biochem. Biophys. Res. Commun. 293 2002 274 283
186. Y.C Zhou D.J Waxman Cross-talk between Janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-α (PPARα) signaling pathways: Growth hormone inhibition of PPARα transcriptional activity mediated by STAT5b J. Biol. Chem. 274 1999 2672 2681
187. Y Zhu C Qi C Calandra M.S Rao J.K Reddy Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor γ Gene Expr. 6 1996 185 195
188. Y Zhu C Qi S Jain M.S Rao J.K Reddy Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor J. Biol. Chem. 272 1997 25500 25506